Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors
Precigen Inc. shares surged Thursday morning after revenue came in ahead of Wall Street expectations, buoyed by the company’s inaugural full commercial quarter for Papzimeos—a boost that also sharply narrowed its loss.